Estimating the Risks of Adverse Radiation Effects After Gamma Knife Radiosurgery for Arteriovenous Malformations
|
|
- Octavia Edwards
- 5 years ago
- Views:
Transcription
1 Estimating the Risks of Adverse Radiation Effects After Gamma Knife Radiosurgery for Arteriovenous Malformations Hideyuki Kano, MD, PhD; John C. Flickinger, MD; Daniel Tonetti, MD; Alan Hsu, MD; Huai-che Yang, MD; Thomas J. Flannery, MD, PhD; Ajay Niranjan, MCh, MBA; L. Dade Lunsford, MD Background and Purpose We evaluated risk factors associated with the development of adverse radiation effects (ARE) after stereotactic radiosurgery (SRS) for cerebral arteriovenous malformations (AVMs). Methods We evaluated 755 patients with AVM who underwent a single Gamma Knife SRS procedure with at least a 2-year minimum follow-up. Eighty-seven patients (12%) underwent previous resection and 128 (17%) had previous embolization. The median target volume was 3.6 ml (range, ml). The median margin dose was 20 Gy (range, Gy). Results Fifty-five patients (7%) developed symptomatic ARE at a median follow-up of 75 months. The cumulative rates of symptomatic ARE were 3.2%, 5.8%, 6.7%, and 7.5% at 1, 2, 3, and 5 years, respectively. Factors associated with a higher rate of developing symptomatic ARE included larger AVM volume, higher margin dose, larger 12-Gy volume, higher Spetzler Martin grade, and higher radiosurgery-based score. The rates of developing symptomatic ARE were higher in the brain stem (22%) or thalamus (16%), compared with AVMs located in other brain locations (4% 8%). Nineteen patients (3%) sustained irreversible new neurological deficits related to ARE, and 1 patient died. The rates of irreversible symptomatic ARE were 0.8%, 1.9%, 2.1%, and 2.8% at 1, 2, 3, and 5 years, respectively. The 5-year cumulative rates of irreversible symptomatic ARE were 9.1% in thalamus, 12.1% in brain stem, and 1.4% in other locations. Conclusions The knowledge of ARE risk rates after AVM radiosurgery can assist informed consent for patients with AVM, their families, and healthcare providers. (Stroke. 2017;48: DOI: /STROKEAHA ) Key Words: adverse radiation effects arteriovenous malformation complication Gamma knife radiation necrosis stereotactic radiosurgery T2 changes Stereotactic radiosurgery (SRS) is an effective and less invasive management option for properly selected brain arteriovenous malformations (AVM). The primary goal of SRS is total AVM nidus obliteration and elimination of future hemorrhage risk. 1 3 Avoidance of treatment-related side effects is an important additional goal. Previous outcomes studies indicate that AVM radiosurgery may be associated with either transient or irreversible adverse radiation effects (ARE) After SRS, serial magnetic resonance imaging (MRI) studies indicate that as many as 30% of patients develop detectable imaging changes adjacent to the treatment volume. 4 7 Symptomatic ARE develop in 3% to 11% of patients. 1,2,5 7,11,12 Previous publications indicate that AVM anatomic location, nidus size, margin dose, 1,5 7,11,12 and the brain volume included in 12 Gy are predictive of symptomatic ARE after AVM radiosurgery. 4 The present study was designed to develop a mathematical risk model for AVM radiosurgery. Methods and Materials Patient Population We performed a retrospective review of 918 patients with AVM who underwent single-stage SRS using the Leksell Gamma Knife (Elekta Instruments, Norcross, GA) at our center between 1987 and Follow-up data after repeat and staged SRS patients were excluded. We excluded 30 patients who died from hemorrhage within 2 years after SRS and 133 patients who were followed up <2 years despite our efforts to contact patients, families, and referring physicians. We identified a final data set of 755 patients with AVM with at least 2 years of imaging and clinical follow-up. The series included 387 male and 368 female patients. The median patient age was 35 years (range, 3 79 years). No patient underwent previous radiation therapy. Eighty-seven patients (12%) underwent SRS after incomplete resection and 128 (17%) had previous embolization. AVMs were originally diagnosed from imaging performed for brain hemorrhage (364 patients or 48%), seizures (165 patients or 22%), refractory headache (145 patients or 19%), or unrelated complaints (81 patients or 11%). The AVMs were located in the cerebral hemispheres in 486 patients, thalamus in 70, brain stem in 55, cerebellum in 55, basal ganglia in Received July 19, 2016; final revision received September 8, 2016; accepted October 18, From the Departments of Neurological Surgery (H.K., D.T., A.H., H.-c.Y., T.J.F., A.N., L.D.L.), Radiation Oncology (J.C.F.), and the Center for Image- Guided Neurosurgery (H.K., J.C.F., D.T., A.H., H.-c.Y., T.J.F., A.N., L.D.L.), University of Pittsburgh School of Medicine, PA. Correspondence to Hideyuki Kano, MD, PhD, Department of Neurological Surgery, University of Pittsburgh, Suite B-400, UPMC Presbyterian, 200 Lothrop St, Pittsburgh, PA kanoh@upmc.edu 2016 American Heart Association, Inc. Stroke is available at DOI: /STROKEAHA
2 Kano et al Adverse Radiation Effects After AVM Radiosurgery 85 50, corpus callosum in 26, and ventricles in 13 (Table 1). Seventyseven patients (10%) had a coexisting arterial aneurysm, and 85 (11%) had a venous outflow varix. A Spetzler Martin grade I AVM was diagnosed in 41 patients (5%), grade II in 214 (28%), grade III in 397 (53%), grade IV in 103 (14%), and grade V in 0 (Table 1). 13 The detailed patient characteristics are shown in Table 1. Radiosurgery Technique Our radiosurgical technique has been described in detail in previous reports. 14 The margin SRS dose included the entire AVM nidus volume, defined as the shunt between the afferent arteries and the draining veins. AVM volumes reduced by embolization were not included in the SRS target volume. SRS was performed with either a Model U, B, C, 4C, or Perfexion Leksell Gamma Knife (Elekta Inc, Atlanta, GA). The median target volume was 3.6 ml ( ml). The median maximal diameter of the AVM nidus was 2.3 cm (range, cm). The median prescription dose delivered to the nidus margin was 20 Gy (13 27 Gy). The median maximum dose was 38 Gy ( Gy). The median number of isocenters was 3 (range, 1 19). The median 12-Gy volume, which is the total volume of tissue including the target and receiving 12 Gy, was 7.7 ml (range, ml). Patient Follow-Up After radiosurgery, patients were instructed to have clinical and imaging assessments at 6-, 12-, 24-, and 36-month intervals. At the Table 1. Arteriovenous Malformations Characteristics n % Location Frontal Temporal Parietal Occipital Corpus callosum Basal ganglia Thalamus Cerebellum Brain stem Intraventricle Presence of varix Presence of coexisting aneurysm including clipped or embolized aneurysm Spetzler Martin grade I II III IV Radiosurgery-based score < > end of 3 years, if MRI suggested complete obliteration, a follow-up angiogram was requested. Complete AVM obliteration was defined as disappearance of the nidus and absence of early venous drainage (using either MRI or angiography). At any time when a new neurological symptom or sign developed, the patient had computed tomography and MRI to rule out hemorrhage or ARE. This retrospective study was approved by the University of Pittsburgh Institutional Review Board. Statistical Analysis The primary end point for statistical analysis was the development of symptomatic ARE. This was defined as any new neurological symptoms and signs without evidence of a new hemorrhage after SRS. Irreversible symptomatic ARE was defined as the documented persistence of neurological deficits for >2 years after the onset of symptoms. Kaplan Meier survival analysis was performed to calculate the rates of symptomatic ARE. The median follow-up period after SRS was 75 months (range, months). Patients were censored when lost to follow-up or at the time of developing symptomatic ARE. The log-rank test was used to assess differences in survival curves and Cox regression was used to assess hazard ratios (HRs) in multivariate analysis. We modeled the end point of symptomatic ARE using a previously described actuarial correction averaging method for multivariable logistic regression analysis. 15,16 Patients who developed ARE within 2 years after SRS or had >2-year follow-up were incorporated in the logistic regression model. A value of P<0.05 was used for the statistical significance. The 12-Gy volume was colinear with margin dose, target volume, and maximum diameter. We performed stepwise modeling with each different variable set with 1 and 2 of each of these variables excluded. Each set yielded the same final model with the same values in stepwise multivariate analysis based on survival analysis. Standard statistical processing software (SPSS, version 22.0; IBM Corp., Armonk, NY) was used. Results Symptomatic AREs Fifty-five patients (6%) developed symptomatic ARE after SRS. Thirty-six patients developed transient symptomatic ARE and 19 had irreversible symptomatic ARE. Table 2 shows detailed information on the symptoms and signs related to both transient and irreversible ARE. One patient with an occipital lobe AVM required surgery to reduce brain edema 27 months after SRS. One patient with a midbrain AVM and unrecognized hydrocephalus died because of ARE 35 months after SRS. Table 2 shows the number of patients who developed both transient symptomatic and irreversible ARE in each location. Eleven of 70 (16%) patients with thalamic AVM developed symptomatic ARE, and 12 of 55 (22%) patients with brain stem AVM developed symptomatic ARE. Patients with AVM in other locations developed symptomatic ARE with a risk of 3.6% to 7.7% depending on the location. The cumulative rates of symptomatic ARE in patients with thalamic AVM at 6, 12, 24, 36, and 60 months were 0%, 7.1%, 12.9%, 12.9%, 14.9%, and 17.1% (Figure 1A). The cumulative rates of symptomatic ARE in patients with brain stem AVM at 6, 12, 24, 36, and 60 months were 8.1%, 10.9%, 18.2%, 22.2%, and 22.2% (Figure 1A). In contrast the 5-year cumulative rate of symptomatic ARE in patients with other non brain stem thalamus AVM was only 5.2% (Figure 1A). The odds ratio between thalamus and non brain stem thalamus AVM was 3.3 (P<0.001; 95% confidence interval [CI], ). The odds ratio between brain stem and non brain
3 86 Stroke January 2017 Table 2. Symptoms and Locations Related to Transient and Irreversible Adverse Radiation Effects Transient+Irreversible Irreversible Symptom Hemiparesis 16 9 Headache 7 0 Seizure 6 0 Sensory dysfunction 4 0 Cerebellar ataxia 1 0 Short-term memory loss 1 0 Facial and ocular movement disorder 1 0 Visual field defect 0 5 Ocular movement disorder 0 4 Reduced level of consciousness 0 1 Location (%) Frontal (n=146) 8 (5.5) 1 (0.7) Temporal (n=122) 5 (4.1) 1 (0.8) Parietal (n=125) 9 (7.2) 1 (0.8) Occipital (n=93) 4 (4.3) 3 (3.2) Corpus callosum (n=26) 1 (3.8) 0 (0) Basal ganglia (n=50) 2 (4.0) 1 (2.0) Thalamus (n=70) 11 (15.7) 5 (7.1) Cerebellum (n=55) 2 (3.6) 1 (1.8) Brain stem (n=55) 12 (21.8) 6 (10.9) Intraventricle (n=13) 1 (7.7) 0 (0) stem thalamus AVM was 4.8 (P<0.0001; 95% CI, ). In the logistic regression model, Figure 1C shows the probability of both transient symptomatic and irreversible ARE for different single-location sites of thalamus, brain stem, and other locations according to 12-Gy volume (Figure 1C). The cumulative rates of symptomatic ARE (transient or irreversible) were 1.9% at 6 months, 3.2% at 12 months, 5.0% at 18 months, 5.8% at 24 months, 6.7% at 36 months, 7.3% at 48 months, and 7.5% at 60 months. In univariate analysis based on Cox proportional hazard model, factors associated with a higher rate of symptomatic ARE included larger maximum diameter, larger target volume, higher margin dose, larger 12-Gy volume, AVM location in thalamus or brain stem, the presence of deep venous drainage, and higher radiosurgerybased score 17 (Figure 2). In multivariate analysis based on Cox proportional hazard model, a greater 12-Gy volume, location of the AVM in thalamus or brain stem, and the presence of deep venous drainage were significantly associated with a higher rate of symptomatic ARE (Figure 2). Among the group of patients with thalamic and brain stem AVM, only larger target volume was significantly associated with higher rate of symptomatic ARE (thalamus: HR, 1.15; 95% CI, ; brain stem: HR, 1.24; 95% CI, ) in multivariate analysis (Figure 2). Among the group of patients with AVM in the other brain locations, only a higher 12-Gy volume was significantly associated with higher rate of symptomatic ARE in multivariate analysis (HR, 1.08; 95% CI, ; Figure 2). Irreversible Symptomatic AREs Of 55 patients who had symptomatic ARE, 19 patients (3%) developed irreversible neurological deficits. The cumulative rates of irreversible ARE-related deficits ARE at 6, 12, 18, 24, 36, 48, and 60 months were 0.4%, 0.8%, 1.4%, 1.9%, 2.1%, 2.6%, and 2.8%. In univariate analysis, factors associated with a higher rate of irreversible symptomatic ARE included the AVM location in thalamus or brain stem, and higher radiosurgery-based score. In multivariate analysis, a greater 12-Gy volume and location in thalamus or brain stem was significantly associated with higher rate of irreversible symptomatic ARE. Among the group of patients with brain stem AVM, only larger target volume was significantly associated with a higher rate of symptomatic ARE (HR, 1.32; 95% CI, ) in multivariate analysis based on Cox proportional hazard model (Figure 3). Among the group of patients with AVM in thalamus and the other brain location, there were no factors associated with higher rate of irreversible symptomatic ARE in multivariate analysis. Five of 70 (7%) patients with thalamic AVM developed irreversible symptomatic ARE, as did 6 of 55 (11%) patients with brain stem AVM. The rates of developing irreversible symptomatic ARE in other locations varied between 0% and 3.2% (Table 2). For patients with thalamic AVM, the cumulative rates of irreversible symptomatic ARE at 6, 12, 24, 36, 48, and 60 months were 0%, 1.4%, 4.5%, 4.5%, 6.7%, and 9.1%, respectively (Figure 1B). For patients with brain stem AVM, the cumulative rates of irreversible symptomatic ARE were 1.9%, 3.8%, 9.8%, 12.1%, 12.1%, and 12.1% (Figure 1B). The 5-year cumulative rate of irreversible symptomatic ARE in patients with other non brain stem thalamic and AVM was 1.4% (Figure 1B). The odds ratio between thalamus and non brain stem thalamus AVM was 6.1 (P=0.002; 95% CI, ). The odds ratio between brain stem and non brain stem thalamus AVM was 9.7 (P<0.0001; 95% CI, ). In the logistic regression model, Figure 1D shows the probability of irreversible symptomatic ARE for different single-location sites of thalamus, brain stem, and other locations according to 12-Gy volume (Figure 1D). Table 3 shows the relationship between dose volume and ARE in each location. A target volume of 1, 4, 13, or 30 ml corresponded to an AVM with an average diameter that was 1.3, 2, 3, and 4 cm in diameter. In the brain stem and thalamic AVMs even smaller target volumes receiving a lower margin dose might develop ARE. Discussion The goal of treatment in cerebral AVMs is complete obliteration to eliminate subsequent intracranial hemorrhage risks while minimizing the risk of developing new treatment-related neurological deficits. The primary disadvantage of SRS lies in the risk of hemorrhage during the latency interval between SRS and total obliteration. Previous SRS outcomes studies indicate that a higher AVM margin dose was significantly associated
4 Kano et al Adverse Radiation Effects After AVM Radiosurgery 87 Figure 1. A, Kaplan Meier curve for symptomatic adverse radiation effects after radiosurgery for arteriovenous malformations (AVM) located in brain stem vs thalamus vs other locations. B, Kaplan Meier curve for irreversible symptomatic adverse radiation effects (AREs) after radiosurgery for AVMs located in brain stem vs thalamus vs other locations. C, Risk prediction curves for AVM patients derived from multivariate logistic regression analysis that correlate 12-Gy volume to risks of developing symptomatic adverse radiation effects according to the AVM location of brain stem, thalamus, and others. D, Risk prediction curves for AVM patients derived from multivariate logistic regression analysis that correlate 12-Gy volume to risks of developing irreversible symptomatic AREs according to the AVM location of brain stem, thalamus, and others. with a higher rate of total obliteration. 3,18 However, the use of higher margin doses also was associated with imaging changes best detected using T2-weighted or fluid-attenuated inversion recovery MR sequences. 19 In the present study, we focused on symptomatic ARE because only such imaging changes after radiosurgery are clinically important only if associated with new neurological symptoms or signs. The AVM dose, brain volume, and AVM location are the most important factors influencing the risk for delayed radiation-related complications. Strategies to optimize the dose delivered to the target while minimizing dose to the surrounding brain enhance the likelihood of AVM obliteration while balancing the risk of ARE. In our previous study, Flickinger et al. 4 constructed statistical models predicting the risk of irreversible radiation sequelae with a 12-Gy volume, ie, the volume of tissue (including the AVM target) receiving 12 Gy. The relationship between target volume and the occurrence of ARE is considered to be dose dependent. 4,5 The likelihood of associated symptoms and the type of symptoms that develop depend on the location of the AVM. 5 7 Flickinger et al 4 reported that the high-risk group of irreversible symptomatic ARE included the AVM locations in the brain stem and thalamus. In the present study, we reconfirmed that AVM location in either the thalamus or brain stem was significantly associated with higher rate of both transient symptomatic and irreversible ARE. We constructed logistic risk prediction curves for symptomatic and irreversible symptomatic ARE from this analysis, with dose and volume parameters for the treatment represented by the single parameter, 12-Gy volume. Other factors that are reported to influence the risk of symptomatic ARE include previous hemorrhage and repeat SRS. 8,20 In the present study, pretreatment hemorrhage was not associated with
5 88 Stroke January 2017 Figure 2. Univariate and multivariate analyses of symptomatic adverse radiation effects (ARE) based on Cox proportional hazard model. AVM indicates arteriovenous malformations; CI, confidence interval; HR, hazard ratio; and NA, not applicable. *Statistical significant in univariate analysis. symptomatic ARE. Interestingly, in the group of patients with thalamic AVM and brain stem AVM, the 12-Gy volume was not associated with symptomatic ARE, whereas the target volume was the only factor associated with higher rate of symptomatic ARE in multivariate analysis (Table 3). Symptomatic ARE reportedly occur in 3% to 11% of patients with AVM who undergo SRS. 1,2,5 7,11,12 Transient symptomatic ARE may also include headache or seizures (for subcortical lobar AVMs) may also occur after SRS. The higher resolution rates of symptoms such as headache or seizures have been studied in reports of AVMs in certainly locations, such as AVMs in the occipitotemporal lobes and near the Syvlvian Fissure. 5,21,22 But visual field defects (transient versus irreversible=0 versus 5), ocular movement disorders (0 versus 4), and hemiparesis (7 versus 9) tended to be irreversible (Table 2). The higher rate of irreversibility was seen in the brain stem (transient versus irreversible=5 versus 6), thalamus (5 versus 6), occipital (1 versus 3), and cerebellum (1 versus 1; Table 2). Flickinger et al 5 reported that 102 of 1255 (8%) patients with AVM who underwent SRS in a multicenter study Figure 3. Univariate and multivariate analyses of irreversible symptomatic adverse radiation effects (ARE) based on Cox proportional hazard model. AVM indicates arteriovenous malformations; CI, confidence interval; HR, hazard ratio; and NA, not applicable. *Statistical significant in univariate analysis
6 Kano et al Adverse Radiation Effects After AVM Radiosurgery 89 Table 3. Relationship Between Volume Dose and AREs in Each Location Brain Stem Thalamus Others n %Oblit ARE n %Oblit ARE n %Oblit ARE Vol, ml Dose, Gy % % (%irrev) % % (%irrev) % % (%irrev) NA NA 0 NA NA (0) (0) (0) (0) (6.3) (5.9) (1.2) (0) (0) (0) (12.5) (0) (0) (15.4) (0) (0.4) (100) (0) (1.8) (20) (10) (1.5) (0) (25) (3.4) NA NA (25) (0) NA NA 0 NA NA (0) NA NA 0 NA NA (0) ARE indicates adverse radiation effects; irrev, irreversible; NA, not applicable; and Oblit, obliteration. developed symptomatic ARE. Eighty of 102 patients who had symptomatic ARE demonstrated evidence of parenchymal radiation injury, 12 had isolated cranial nerve neuropathies, and 10 had new or worsened seizures. Forty-percent of symptomatic ARE had complete symptom resolution. In the present study, patients who developed headache and seizures tended to have transient events, whereas patients who developed cranial nerve or visual field defects proved to have long-lasting AREs. Only 2 patients required surgical resection of their AVM because of persistent ARE symptoms. We prescribe oral corticosteroids for transient ( 2 weeks), whereas for persistent symptoms, we prescribe a 90-day trial of vitamin E (400 iu BID) and pentoxifylline (400 mg BID). Weaknesses of the Present Study We acknowledge the weaknesses of this retrospective outcome analysis. During our 28-year AVM experience, our knowledge of dose volume relationships, conformality and selectivity of treatment planning, and reliance on both angiographic and 3-dimensional MRI data, gradually changed. It is likely that patients treated in the latter years of this study benefitted from our expanded knowledge and improving technique. Optimization of target selection and dose planning has reached a mature phase. The incidence of ARE may be slightly under- or overestimated because patients who were followed up <2 years (14%) were excluded in this study. Conclusions The knowledge of ARE risk rates after AVM radiosurgery can assist clinical decision making for patients and healthcare providers. We found that the risks of symptomatic ARE from AVM radiosurgery can be predicted according to location and the 12-Gy volume. We anticipate that we will be able to gather additional multicenter experience to verify and extend these predictions. Acknowledgments We thank Douglas Kondziolka, MD (New York University Langone Medical Center), for significant contributions to patient management at the University of Pittsburgh. Sources of Funding This study was supported by Elekta Research Grant. Disclosures Dr Lunsford is a stock holder for AB Elekta. The other authors report no conflicts. References 1. Friedman WA, Bova FJ. Linear accelerator radiosurgery for arteriovenous malformations. J Neurosurg. 1992;77: doi: / jns Lunsford LD, Kondziolka D, Flickinger JC, Bissonette DJ, Jungreis CA, Maitz AH, et al. Stereotactic radiosurgery for arteriovenous malformations of the brain. J Neurosurg. 1991;75: doi: / jns Pollock BE, Flickinger JC, Lunsford LD, Maitz A, Kondziolka D. Factors associated with successful arteriovenous malformation radiosurgery. Neurosurgery. 1998;42: , discussion Flickinger JC, Kondziolka D, Lunsford LD, Kassam A, Phuong LK, Liscak R, et al. Development of a model to predict permanent symptomatic postradiosurgery injury for arteriovenous malformation patients. Arteriovenous Malformation Radiosurgery Study Group. Int J Radiat Oncol Biol Phys. 2000;46: Flickinger JC, Kondziolka D, Lunsford LD, Pollock BE, Yamamoto M, Gorman DA, et al. A multi-institutional analysis of complication outcomes after arteriovenous malformation radiosurgery. Int J Radiat Oncol Biol Phys. 1999;44: Flickinger JC, Kondziolka D, Pollock BE, Maitz AH, Lunsford LD. Complications from arteriovenous malformation radiosurgery: multivariate analysis and risk modeling. Int J Radiat Oncol Biol Phys. 1997;38: Flickinger JC, Lunsford LD, Kondziolka D, Maitz AH, Epstein AH, Simons SR, et al. Radiosurgery and brain tolerance: an analysis of neurodiagnostic imaging changes after gamma knife radiosurgery for arteriovenous malformations. Int J Radiat Oncol Biol Phys. 1992;23:19 26.
7 90 Stroke January Karlsson B, Lax I, Söderman M. Factors influencing the risk for complications following Gamma Knife radiosurgery of cerebral arteriovenous malformations. Radiother Oncol. 1997;43: Lax I, Karlsson B. Prediction of complications in gamma knife radiosurgery of arteriovenous malformation. Acta Oncol. 1996;35: Voges J, Treuer H, Sturm V, Büchner C, Lehrke R, Kocher M, et al. Risk analysis of linear accelerator radiosurgery. Int J Radiat Oncol Biol Phys. 1996;36: Liscák R, Vladyka V, Simonová G, Urgosík D, Novotný J Jr, Janousková L, et al. Arteriovenous malformations after Leksell gamma knife radiosurgery: rate of obliteration and complications. Neurosurgery. 2007;60: , discussion doi: /01.NEU A. 12. Yamamoto Y, Coffey RJ, Nichols DA, Shaw EG. Interim report on the radiosurgical treatment of cerebral arteriovenous malformations. The influence of size, dose, time, and technical factors on obliteration rate. J Neurosurg. 1995;83: doi: /jns Spetzler RF, Martin NA. A proposed grading system for arteriovenous malformations. J Neurosurg. 1986;65: doi: / jns Kano H, Kondziolka D, Flickinger JC, Yang HC, Park KJ, Flannery TJ, et al. Aneurysms increase the risk of rebleeding after stereotactic radiosurgery for hemorrhagic arteriovenous malformations. Stroke. 2012;43: doi: /STROKEAHA Flickinger JC, Kondziolka D, Lunsford LD. Dose and diameter relationships for facial, trigeminal, and acoustic neuropathies following acoustic neuroma radiosurgery. Radiother Oncol. 1996;41: Flickinger JC, Kondziolka D, Maitz AH, Lunsford LD. Analysis of neurological sequelae from radiosurgery of arteriovenous malformations: how location affects outcome. Int J Radiat Oncol Biol Phys. 1998;40: Pollock BE, Flickinger JC. A proposed radiosurgery-based grading system for arteriovenous malformations. J Neurosurg. 2002;96: doi: /jns Kano H, Kondziolka D, Flickinger JC, Yang HC, Park KJ, Flannery TJ, et al. Aneurysms increase the risk of rebleeding after stereotactic radiosurgery for hemorrhagic arteriovenous malformations. Stroke. 2012;43: doi: /STROKEAHA Cohen-Inbar O, Lee CC, Xu Z, Schlesinger D, Sheehan JP. A quantitative analysis of adverse radiation effects following Gamma Knife radiosurgery for arteriovenous malformations. J Neurosurg. 2015;123: doi: / JNS Hayhurst C, Monsalves E, van Prooijen M, Cusimano M, Tsao M, Menard C, et al. Pretreatment predictors of adverse radiation effects after radiosurgery for arteriovenous malformation. Int J Radiat Oncol Biol Phys. 2012;82: doi: /j.ijrobp Bowden G, Kano H, Tonetti D, Niranjan A, Flickinger J, Arai Y, et al. Stereotactic radiosurgery for sylvian fissure arteriovenous malformations with emphasis on hemorrhage risks and seizure outcomes. J Neurosurg. 2014;121: doi: / JNS Hadjipanayis CG, Levy EI, Niranjan A, Firlik AD, Kondziolka D, Flickinger JC, et al. Stereotactic radiosurgery for motor cortex region arteriovenous malformations. Neurosurgery. 2001;48:70 76, discussion 76.
Despite recent progress in microsurgical techniques, endovascular
Application of Single-Stage Stereotactic Radiosurgery for Cerebral Arteriovenous Malformations >10 cm 3 Shunya Hanakita, MD; Tomoyuki Koga, MD, PhD; Masahiro Shin, MD, PhD; Hiroshi Igaki, MD, PhD; Nobuhito
More informationANALYSIS OF TREATMENT OUTCOMES WITH LINAC BASED STEREOTACTIC RADIOSURGERY IN INTRACRANIAL ARTERIOVENOUS MALFORMATIONS
ANALYSIS OF TREATMENT OUTCOMES WITH LINAC BASED STEREOTACTIC RADIOSURGERY IN INTRACRANIAL ARTERIOVENOUS MALFORMATIONS Dr. Maitri P Gandhi 1, Dr. Chandni P Shah 2 1 Junior resident, Gujarat Cancer & Research
More informationIntracranial arteriovenous malformations (AVMs)
clinical article J Neurosurg 123:945 953, 2015 A quantitative analysis of adverse radiation effects following Gamma Knife radiosurgery for arteriovenous malformations Or Cohen-Inbar, MD, PhD, 1 Cheng-Chia
More informationOver the last 25 years the management options for. Stereotactic radiosurgery for arteriovenous malformations of the cerebellum.
J Neurosurg 120:583 590, 2014 AANS, 2014 Stereotactic radiosurgery for arteriovenous malformations of the cerebellum Clinical article Greg Bowden, M.D., M.Sc., 1,3,5 Hideyuki Kano, M.D., Ph.D., 1,3 Daniel
More informationResults of acoustic neuroma radiosurgery: an analysis of 5 years experience using current methods
See the Letter to the Editor and the Response in this issue in Neurosurgical Forum, pp 141 142. J Neurosurg 94:1 6, 2001 Results of acoustic neuroma radiosurgery: an analysis of 5 years experience using
More informationSpetzler-Martin Grade III arteriovenous malformations. Radiosurgery for Spetzler-Martin Grade III arteriovenous malformations.
See the corresponding editorial in this issue, pp 955 958. J Neurosurg 120:959 969, 2014 AANS, 2014 Radiosurgery for Spetzler-Martin Grade III arteriovenous malformations Clinical article Dale Ding, M.D.,
More informationLONG-TERM FOLLOW-UP OF ACOUSTIC SCHWANNOMA RADIOSURGERY WITH MARGINAL TUMOR DOSES OF 12 TO 13 Gy
doi:10.1016/j.ijrobp.2007.01.001 Int. J. Radiation Oncology Biol. Phys., Vol. 68, No. 3, pp. 845 851, 2007 Copyright 2007 Elsevier Inc. Printed in the USA. All rights reserved 0360-3016/07/$ see front
More informationIMAGE-GUIDED RADIOSURGERY USING THE GAMMA KNIFE
IMAGE-GUIDED RADIOSURGERY USING THE GAMMA KNIFE L. D. LUNSFORD INTRODUCTION Image guided brain surgery became a reality in the mid-1970s after the introduction of the first methods to obtain axial imaging
More informationInfluenced by the high morbidity and mortality associated
Hemorrhage Risk of Cerebral Arteriovenous Malformations Before and During the Latency Period After Gamma Knife Radiosurgery Chun-Po Yen, MD; Jason P. Sheehan, MD, PhD; Lucia Schwyzer, MD; David Schlesinger,
More informationLong-term control of large pontine arteriovenous malformation using gamma knife therapy: a review with illustrative case
Long-term control of large pontine arteriovenous malformation using gamma knife therapy: a review with illustrative case Martin M. Mortazavi 1, Daxa Patel 1, Christoph J. Griessenauer 1, R. Shane Tubbs
More informationThe Risk of Hemorrhage after Radiosurgery for Cerebral Arteriovenous Malformations
The new england journal of medicine original article The Risk of Hemorrhage after Radiosurgery for Cerebral Arteriovenous Malformations Keisuke Maruyama, M.D., Nobutaka Kawahara, M.D., Ph.D., Masahiro
More informationUpdate on IGKRF Activities
Stereotactic radiosurgery research, education and publishing for the purpose of improving public health Fall 2016 In this issue: Update on IGKRF Activities The IGKRF Recently Published Articles Topics
More informationLeksell Gamma Knife References 1992 December Gamma Knife Radiosurgery
Leksell Gamma Knife References 1992 December 2011 Gamma Knife Radiosurgery Vascular Malformation Bibliography 2006-2016 VASCULAR MALFORMATIONS Includes Gamma Knife-focused abstracts posted to PubMed during
More informationStaged-Volume Radiosurgery of Large AVMs
Case Study Staged-Volume Radiosurgery of Large AVMs Using Gamma Knife Technology Institution New York University Langone Medical Center Location New York City, NY Patient 18 patients Diagnosis Each patient
More informationMichael K. Morgan, MD, 1 Markus K. Hermann Wiedmann, MD, 1 Marcus A. Stoodley, PhD, 1 and Gillian Z. Heller, PhD 2
CLINICAL ARTICLE J Neurosurg 127:1105 1116, 2017 Microsurgery for Spetzler-Ponce Class A and B arteriovenous malformations utilizing an outcome score adopted from Gamma Knife radiosurgery: a prospective
More informationCerebral arteriovenous malformations (AVMs) are
CLINICAL ARTICLE J Neurosurg 126:852 858, 2017 Comparative analysis of arteriovenous malformation grading scales in predicting outcomes after stereotactic radiosurgery Bruce E. Pollock, MD, 1,2 Curtis
More informationSurgical Neurology International
Surgical Neurology International OPEN ACCESS For entire Editorial Board visit : http://www.surgicalneurologyint.com Editor: James I. Ausman, MD, PhD University of California, Los Angeles, CA, USA Original
More informationForward treatment planning techniques to reduce the normalization effect in Gamma Knife radiosurgery
Received: 7 November 2016 Revised: 9 August 2017 Accepted: 21 August 2017 DOI: 10.1002/acm2.12193 RADIATION ONCOLOGY PHYSICS Forward treatment planning techniques to reduce the normalization effect in
More informationDOWNLOAD PDF RADIOSURGERY FOR CAVERNOUS MALFORMATIONS IN BASAL GANGLIA, THALAMUS AND BRAINSTEM KIDA, Y
Chapter 1 : Stereotactic radiosurgery for cavernous malformations â Mayo Clinic Most of the lesions were located in the brainstem, followed by the lobar region, cerebellum, thalamus, and basal ganglia
More informationBr a i n metastases occur in 20 40% of all patients. The results of resection after stereotactic radiosurgery for brain metastases.
J Neurosurg 111:825 831, 2009 The results of resection after stereotactic radiosurgery for brain metastases Clinical article Hi d e y u k i Ka n o, M.D., Ph.D., 1,3 Do u g l a s Ko n d z i o l k a, M.D.,
More informationThe clinical significance of persistent trigeminal nerve contrast enhancement in patients who undergo repeat radiosurgery
CLINICAL ARTICLE J Neurosurg 127:219 225, 2017 The clinical significance of persistent trigeminal nerve contrast enhancement in patients who undergo repeat radiosurgery Seyed H. Mousavi, MD, 1 Berkcan
More informationStereotactic Radiosurgery and Stereotactic Body Radiation Therapy
Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy Policy Number: Original Effective Date: MM.05.008 05/12/1999 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST 03/01/2013 Section:
More informationVASCULAR MALFORMATIONS. Owen Samuels, MD Adam Webb, MD Emory University
VASCULAR MALFORMATIONS Owen Samuels, MD Adam Webb, MD Emory University Introduction Brain and spinal cord vascular malformations can be separated into five main categories: 1) Arteriovenous malformation,
More informationDECISION MAKING IN AVM TREATMENT STRATEGY TREATMENT BOARD SYSTEM AT TOHOKU UNIVERSITY
Kitakanto Med. J. (S1) : 79-84, 1998 79 DECISION MAKING IN AVM TREATMENT STRATEGY TREATMENT BOARD SYSTEM AT TOHOKU UNIVERSITY Takashi Yoshimoto, Hidefumi Jokura Department of Neurosurgery, Tohoku University
More informationThe New England Journal of Medicine LONG-TERM OUTCOMES AFTER RADIOSURGERY FOR ACOUSTIC NEUROMAS
LONG-TERM OUTCOMES AFTER RADIOSURGERY FOR ACOUSTIC NEUROMAS DOUGLAS KONDZIOLKA, M.D., L. DADE LUNSFORD, M.D., MARK R. MCLAUGHLIN, M.D., AND JOHN C. FLICKINGER, M.D. ABSTRACT Background Stereotactic radiosurgery
More informationXiaochuan Huo, PhD, Yuhua Jiang, PhD, Xianli Lv, PhD, Hongchao Yang, MD, Yang Zhao, MD, and
clinical article J Neurosurg 124:767 776, 2016 Gamma Knife surgical treatment for partially embolized cerebral arteriovenous malformations Xiaochuan Huo, PhD, Yuhua Jiang, PhD, Xianli Lv, PhD, Hongchao
More informationStereotactic radiosurgery with neoadjuvant embolization of larger arteriovenous malformations: An institutional experience
Thomas Jefferson University Jefferson Digital Commons Department of Neurosurgery Faculty Papers Department of Neurosurgery 1-22-2014 Stereotactic radiosurgery with neoadjuvant embolization of larger arteriovenous
More informationNeurological Change after Gamma Knife Radiosurgery for Brain Metastases Involving the Motor Cortex
ORIGINAL ARTICLE Brain Tumor Res Treat 2016;4(2):111-115 / pissn 2288-2405 / eissn 2288-2413 http://dx.doi.org/10.14791/btrt.2016.4.2.111 Neurological Change after Gamma Knife Radiosurgery for Brain Metastases
More informationMethods. Treatment options for intracranial arteriovenous malformations
AJNR Am J Neuroradiol 25:1139 1143, August 2004 Complete Obliteration of Intracranial Arteriovenous Malformation with Endovascular Cyanoacrylate Embolization: Initial Success and Rate of Permanent Cure
More informationGamma Knife radiosurgery with CT image-based dose calculation
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, VOLUME 16, NUMBER 6, 2015 Gamma Knife radiosurgery with CT image-based dose calculation Andy (Yuanguang) Xu, 1a Jagdish Bhatnagar, 1 Greg Bednarz, 1 Ajay Niranjan,
More informationBrain Arteriovenous Malformations Endovascular Therapy and Associated Therapeutic Protocols Jorge Guedes Cabral de Campos
Endovascular Therapy and Associated Therapeutic Protocols Jorge Guedes Cabral de Campos Neuroradiology Department Hospital de Santa Maria University of Lisbon CEREBRAL AVM CLINICAL / EPIDEMIOLOGY Brain
More informationAc o u s t i c neuromas, also known as vestibular. Predictors of hearing preservation after stereotactic radiosurgery for acoustic neuroma
J Neurosurg 111:863 873, 2009 Predictors of hearing preservation after stereotactic radiosurgery for acoustic neuroma Clinical article Hi d e y u k i Ka n o, M.D., Ph.D., 1,3 Do u g l a s Ko n d z i o
More informationEMBOLIZATION OF ARTERIOVENOUS FISTULA AFTER RADIOSURGERY FOR MULTIPLE CEREBRAL ARTERIOVENOUS MALFORMATIONS
Arteriovenous fistula after radiosurgery for multiple CAVM EMBOLIZATION OF ARTERIOVENOUS FISTULA AFTER RADIOSURGERY FOR MULTIPLE CEREBRAL ARTERIOVENOUS MALFORMATIONS Chao-Bao Luo, Wan-Yuo Guo, Michael
More informationOcclusive hyperemia: a theory for the hemodynamic complications following resection of intracerebral arteriovenous malformations
J Neurosurg 78: 167-175, 1993 Occlusive hyperemia: a theory for the hemodynamic complications following resection of intracerebral arteriovenous malformations NAYEF R. F. AL-RODHAN, M.D., PH.D., THORALF
More informationA Population-Based Study on the Uptake and Utilization of Stereotactic Radiosurgery (SRS) for Brain Metastasis in Nova Scotia
A Population-Based Study on the Uptake and Utilization of Stereotactic Radiosurgery (SRS) for Brain Metastasis in Nova Scotia Gaurav Bahl, Karl Tennessen, Ashraf Mahmoud-Ahmed, Dorianne Rheaume, Ian Fleetwood,
More informationCerebellopontine angle (CPA) meningiomas are a. Stereotactic radiosurgery for cerebellopontine angle meningiomas. Clinical article
J Neurosurg 120:708 715, 2014 AANS, 2014 Stereotactic radiosurgery for cerebellopontine angle meningiomas Clinical article Seong-Hyun Park, M.D., Ph.D., 1,3,4 Hideyuki Kano, M.D., Ph.D., 1,3 Ajay Niranjan,
More informationRadiosurgery for unruptured cerebral arteriovenous malformations in pediatric patients
Acta Neurochir (2015) 157:281 291 DOI 10.1007/s00701-014-2305-4 CLINICAL ARTICLE - VASCULAR Radiosurgery for unruptured cerebral arteriovenous malformations in pediatric patients Dale Ding & Zhiyuan Xu
More informationStereotactic radiosurgery (SRS) is the least invasive
» This article has been updated from its originally published version to correct Table 1 and terminology in the text. See the corresponding erratum notice, DOI: 10.3171/2017.3.JNS151624a. «CLINICAL ARTICLE
More informationSeizure control of Gamma Knife radiosurgery for non-hemorrhagic arteriovenous malformations
Acta Neurochir Suppl (2006) 99: 97 101 # Springer-Verlag 2006 Printed in Austria Seizure control of Gamma Knife radiosurgery for non-hemorrhagic arteriovenous malformations Y. J. Lim, C. Y. Lee, J. S.
More informationStereotactic Radiosurgery for Glossopharyngeal Neuralgia: An International Multicenter Study
Stereotactic Radiosurgery for Glossopharyngeal Neuralgia: An International Multicenter Study University of Pittsburgh Hideyuki Kano, MD, PhD L. Dade Lunsford, MD Hospital Na Homolce, Prague Dusan Urgosik,
More informationClinical Commissioning Policy: Arteriovenous Malformations. December Reference : NHSCB/D5/4
Clinical Commissioning Policy: Arteriovenous Malformations December 2012 Reference : NHSCB/D5/4 NHS Commissioning Board Clinical Commissioning Policy: Arteriovenous Malformations First published: December
More informationStereotactic Radiosurgery and Stereotactic Body Radiation Therapy
Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy Policy Number: Original Effective Date: MM.05.008 05/12/1999 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST 04/01/2014 Section:
More informationSerial Follow-up MR Imaging after Gamma Knife Radiosurgery for Vestibular Schwannoma
AJNR Am J Neuroradiol 21:1540 1546, September 2000 Serial Follow-up MR Imaging after Gamma Knife Radiosurgery for Vestibular Schwannoma Hiroyuki Nakamura, Hidefumi Jokura, Kou Takahashi, Nagatoshi Boku,
More informationMicrosurgical Resection of Incompletely Obliterated Intracranial Arteriovenous Malformations Following Stereotactic Radiosurgery
II-2. Selection of Treatment Microsurgical Resection of Incompletely Obliterated Intracranial Arteriovenous Malformations Following Stereotactic Radiosurgery Steven D. CHANG*, Gary K. STEINBERG*, Richard
More informationBrain AVM with Accompanying Venous Aneurysm with Intracerebral and Intraventricular Hemorrhage
Cronicon OPEN ACCESS EC PAEDIATRICS Case Report Brain AVM with Accompanying Venous Aneurysm with Intracerebral and Intraventricular Hemorrhage Dimitrios Panagopoulos* Neurosurgical Department, University
More informationChapter 28 Emerging Indications in Stereotactic Radiosurgery: The First Application of Cellular Surgery
Chapter 28 Emerging Indications in Stereotactic Radiosurgery: The First Application of Cellular Surgery Douglas Kondziolka, M.D., M.Sc., F.R.C.S.C., L. Dade Lunsford, M.D., John C. Flickinger, M.D., and
More informationStereotactic Radiosurgery and Stereotactic Body Radiation Therapy
Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy Policy Number: Original Effective Date: MM.05.008 05/12/1999 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST Integration 04/01/2015
More informationOtolaryngologist s Perspective of Stereotactic Radiosurgery
Otolaryngologist s Perspective of Stereotactic Radiosurgery Douglas E. Mattox, M.D. 25 th Alexandria International Combined ORL Conference April 18-20, 2007 Acoustic Neuroma Benign tumor of the schwann
More informationVascular Malformations of the Brain: A Review of Imaging Features and Risks
Vascular Malformations of the Brain: A Review of Imaging Features and Risks Comprehensive Neuroradiology: Best Practices October 27-30, 2016 Sudhakar R. Satti, MD Associate Director Neurointerventional
More informationNeurosurgical decision making in structural lesions causing stroke. Dr Rakesh Ranjan MS, MCh, Dip NB (Neurosurgery)
Neurosurgical decision making in structural lesions causing stroke Dr Rakesh Ranjan MS, MCh, Dip NB (Neurosurgery) Subarachnoid Hemorrhage Every year, an estimated 30,000 people in the United States experience
More informationDiagnosis and Management of AVM in the Pregnant Patient
Diagnosis and Management of AVM in the Pregnant Patient Wade Cooper, D.O. University of Michigan Assistant Professor Departments of Neurology & Anesthesiology Disclosures Wade Cooper - None Developmental
More informationStereotactic radiosurgery for the treatment of melanoma and renal cell carcinoma brain metastases
ONCOLOGY REPORTS 29: 407-412, 2013 Stereotactic radiosurgery for the treatment of melanoma and renal cell carcinoma brain metastases SHELLY LWU 1, PABLO GOETZ 1, ERIC MONSALVES 1, MANDANA ARYAEE 1, JULIUS
More informationWe have previously reported good clinical results
J Neurosurg 113:48 52, 2010 Gamma Knife surgery as sole treatment for multiple brain metastases: 2-center retrospective review of 1508 cases meeting the inclusion criteria of the JLGK0901 multi-institutional
More informationThe role of SRS in the management of metastatic. Motor function after stereotactic radiosurgery for brain metastases in the region of the motor cortex
J Neurosurg 119:683 688, 2013 AANS, 2013 Motor function after stereotactic radiosurgery for brain metastases in the region of the motor cortex Clinical article Neal Luther, M.D., 1 Douglas Kondziolka,
More informationRadiographic and statistical analysis of Brain Arteriovenous Malformations.
Radiographic and statistical analysis of Brain Arteriovenous Malformations. Poster No.: C-0996 Congress: ECR 2017 Type: Educational Exhibit Authors: C. E. Rodriguez 1, A. Lopez Moreno 1, D. Sánchez Paré
More informationFOR PUBLIC CONSULTATION ONLY STEREOTACTIC RADIOSURGERY/ STEROTACTIC RADIOTHERAPY FOR HAEMANGIOBLASTOMA
1 EVIDENCE SUMMARY REPORT FOR PUBLIC CONSULTATION ONLY STEREOTACTIC RADIOSURGERY/ STEROTACTIC RADIOTHERAPY FOR HAEMANGIOBLASTOMA QUESTIONS TO BE ADDRESSED: 1. What is the evidence for the clinical effectiveness
More informationLong term effects of Gamma knife Radiosurgery for treatment of cerebral arteriovenous malformations
Original Research Medical Journal of Islamic Republic of Iran, Vol. 25, No. 3, Nov. 2011, pp. 119-126 Long term effects of Gamma knife Radiosurgery for treatment of cerebral arteriovenous malformations
More informationSupratentorial cerebral arteriovenous malformations : a clinical analysis
Original article: Supratentorial cerebral arteriovenous malformations : a clinical analysis Dr. Rajneesh Gour 1, Dr. S. N. Ghosh 2, Dr. Sumit Deb 3 1Dept.Of Surgery,Chirayu Medical College & Research Centre,
More informationGamma Knife Surgery for Brain Metastasis from Renal Cell Carcinoma : Relationship Between Radiological Characteristics and Initial Tumor Response
online ML Comm www.jkns.or.kr Clinical Article Jin Wook Kim, M.D. Jung Ho Han, M.D. Chul-Kee Park, M.D. Hyun-Tai Chung, Ph.D. Sun Ha Paek, M.D. Dong Gyu Kim, M.D. Department of Neurosurgery Seoul National
More informationBiomedical Research 2017; 28 (2):
Biomedical Research 2017; 28 (2): 957-962 ISSN 0970-938X www.biomedres.info Analysis on the effect and prognostic factors of cerebral arteriovenous malformations (AVM) after endovascular embolization combined
More informationCerebral metastases occur in 20% 40% of cancer
See the corresponding editorial, DOI: 10.3171/2012.1.JNS12103. DOI: 10.3171/2012.4.JNS11870 Stereotactic radiosurgery using the Leksell Gamma Knife Perfexion unit in the management of patients with 10
More informationUnruptured Epileptogenic Brain Arteriovenous Malformations
DOI: 10.5137/1019-5149.JTN.9190-13.1 Received: 31.08.2013 / Accepted: 24.09.2013 Published Online: 16.02.2016 Original Investigation Unruptured Epileptogenic Brain Arteriovenous Malformations Yong SUN
More informationWhat Is an Arteriovenous malformation (AVM)?
American Society of Neuroradiology What Is an Arteriovenous malformation (AVM)? From the Cerebrovascular Imaging and Intervention Committee of the American Heart Association Cardiovascular Council Randall
More informationIntensity-modulated stereotactic radiosurgery for arteriovenous malformations: guidance for treatment planning
Sonier et al. Radiation Oncology 2014, 9:73 RESEARCH Open Access Intensity-modulated stereotactic radiosurgery for arteriovenous malformations: guidance for treatment planning Marcus Sonier 1,3*, Ermias
More informationArteriovenous malformations in the basal ganglia and thalamus: management and results in 101 cases
J Neurosurg 88:285 292, 1998 Arteriovenous malformations in the basal ganglia and thalamus: management and results in 101 cases TOMIO SASAKI, M.D., PH.D., HIROKI KURITA, M.D., ISAMU SAITO, M.D., PH.D.,
More informationFOR PUBLIC CONSULTATION ONLY STEREOTACTIC RADIOSURGERY/ STEROTACTIC RADIOTHERAPY FOR PILOCYTIC ASTROCYTOMA
1 EVIDENCE SUMMARY REPORT FOR PUBLIC CONSULTATION ONLY STEREOTACTIC RADIOSURGERY/ STEROTACTIC RADIOTHERAPY FOR PILOCYTIC ASTROCYTOMA QUESTIONS TO BE ADDRESSED: SUMMARY 1. What is the evidence for the clinical
More informationGamma knife radiosurgery for Koos grade 4 vestibular schwannomas
Gamma knife radiosurgery for Koos grade 4 vestibular schwannomas David Mathieu MD FRCSC, Christian Iorio-Morin MD PhD, Fahd Al Subaie MD MSc FRCSC Division of neurosurgery, Université de Sherbrooke, Centre
More informationA lthough more than 90% of intracranial meningiomas are
226 PAPER Complications after gamma knife radiosurgery for benign meningiomas J H Chang, J W Chang, J Y Choi, Y G Park, S S Chung... See end of article for authors affiliations... Correspondence to: Professor
More informationS tereotactic radiosurgery, whether delivered by a gamma
1536 PAPER Gamma knife stereotactic radiosurgery for unilateral acoustic neuromas J G Rowe, M W R Radatz, L Walton, A Hampshire, S Seaman, A A Kemeny... See end of article for authors affiliations... Correspondence
More informationBrain Edema after Repeat Gamma Knife Radiosurgery for a Large Arteriovenous Malformation: A Case Report
Posted online 2016 Jul. 19 Exp Neurobiol. 2016 Aug;25(4) pissn 1226-2560 eissn 2093-8144 Case Report Brain Edema after Repeat Gamma Knife Radiosurgery for a Large Arteriovenous Malformation: A Case Report
More informationGamma Knife Surgery Vascular Malformations Bibliography _Omslag_LGKS.indd
Gamma Knife Surgery Vascular Malformations Bibliography 2006-2012 1 Neurology.2012;Epub 2012/03/31 Radiosurgery for unruptured cerebral arteriovenous malformations: Long-term seizure outcome Yang, S. Y.,
More informationEvidence Based Medicine for Gamma Knife Radiosurgery. Metastatic Disease GAMMA KNIFE SURGERY
GAMMA KNIFE SURGERY Metastatic Disease Evidence Based Medicine for Gamma Knife Radiosurgery Photos courtesy of Jean Régis, Timone University Hospital, Marseille, France Brain Metastases The first report
More informationStereotactic Radiosurgery and Stereotactic Body Radiation Therapy
Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy Policy Number: Original Effective Date: MM.05.008 05/12/1999 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST Integration 11/20/2015
More informationSeizure, second only to hemorrhage, is a common
CLINICAL ARTICLE J Neurosurg 126:845 851, 2017 Seizure outcomes after stereotactic radiosurgery for the treatment of cerebral arteriovenous malformations Benjamin J. Ditty, MD, Nidal B. Omar, MD, Paul
More informationLeksell Gamma Knife Icon. Treatment information
Leksell Gamma Knife Icon Treatment information You may be feeling frightened or overwhelmed by your recent diagnosis. It can be confusing trying to process a diagnosis, understand a new and challenging
More informationThe outcome of treatment for arteriovenous malformations of the brain: A five-year retrospective series from the Philippines
Neurology Asia 2006; 11 : 91 96 ORIGINAL ARTICLES The outcome of treatment for arteriovenous malformations of the brain: A five-year retrospective series from the Philippines Roland Mark M GIGATARAS MD,
More informationHemorrhagic vestibular schwannoma: an unusual clinical entity Case report
Neurosurg Focus 5 (3):Article 9, 1998 Hemorrhagic vestibular schwannoma: an unusual clinical entity Case report Dean Chou, M.D., Prakash Sampath, M.D., and Henry Brem, M.D. Departments of Neurological
More informationStereotactic Radiosurgery of World Health Organization Grade II and III Intracranial Meningiomas
Stereotactic Radiosurgery of World Health Organization Grade II and III Intracranial Meningiomas Treatment Results on the Basis of a 22-Year Experience Bruce E. Pollock, MD 1,2 ; Scott L. Stafford, MD
More informationLong term neuroimaging and clinical outcome of brain Arteriovenous Malformations (bavm) treated with stereotactic radiosurgery (SRS).
Long term neuroimaging and clinical outcome of brain Arteriovenous Malformations (bavm) treated with stereotactic radiosurgery (SRS). Poster No.: C-2489 Congress: ECR 2012 Type: Scientific Exhibit Authors:
More informationHigher dose rate Gamma Knife radiosurgery may provide earlier and longer-lasting pain relief for patients with trigeminal neuralgia
clinical article J Neurosurg 123:961 968, 2015 Higher dose rate Gamma Knife radiosurgery may provide earlier and longer-lasting pain relief for patients with trigeminal neuralgia John Y. K. Lee, MD, MSCE,
More informationStereotactic radiosurgery for idiopathic trigeminal neuralgia
J Neurosurg 97:347 353, 2002 Stereotactic radiosurgery for idiopathic trigeminal neuralgia BRUCE E. POLLOCK, M.D., LOI K. PHUONG, M.D., DEBORAH A. GORMAN, R.N., ROBERT L. FOOTE, M.D., AND SCOTT L. STAFFORD,
More informationStereotactic radiosurgery in the management of acoustic neuromas associated with neurofibromatosis Type 2
Stereotactic radiosurgery in the management of acoustic neuromas associated with neurofibromatosis Type 2 Brian R. Subach, M.D., Douglas Kondziolka, M.D., M. Sc., F.R.C.S.(C), L. Dade Lunsford, M.D., F.A.C.S.,
More informationUntangling Cerebral Dural Arteriovenous Fistulas
Untangling Cerebral Dural Arteriovenous Fistulas Bradley A. Gross, MD Assistant Professor, Dept of Neurosurgery, University of Pittsburgh September 2017 davfs Definition Clinical Presentation Natural History
More informationStereotactic Radiosurgery and Stereotactic Body Radiation Therapy
Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy Policy Number: Original Effective Date: MM.05.008 05/12/1999 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST Integration 04/01/2017
More informationRadiosurgery for temporal lobe arteriovenous malformations: effect of temporal location on seizure outcomes
clinical article J Neurosurg 123:924 934, 2015 Radiosurgery for temporal lobe arteriovenous malformations: effect of temporal location on seizure outcomes Dale Ding, MD, 1 Mark Quigg, MD, MSc, 2 Robert
More informationSurvival and Intracranial Control of Patients With 5 or More Brain Metastases Treated With Gamma Knife Stereotactic Radiosurgery
ORIGINAL ARTICLE Survival and Intracranial Control of Patients With 5 or More Brain Metastases Treated With Gamma Knife Stereotactic Radiosurgery Ann C. Raldow, BS,* Veronica L. Chiang, MD,w Jonathan P.
More informationLocal control of brain metastases by stereotactic radiosurgery in relation to dose to the tumor margin
J Neurosurg 104:907 912, 2006 Local control of brain metastases by stereotactic radiosurgery in relation to dose to the tumor margin MICHAEL A. VOGELBAUM, M.D., PH.D., LILYANA ANGELOV, M.D., SHIH-YUAN
More informationCerebral haemorrhage from a remote varix in the venous outflow of an arteriovenous malformation treated successfully by embolisation
The British Journal of Radiology, 83 (2010), e129 e134 CASE REPORT Cerebral haemorrhage from a remote varix in the venous outflow of an arteriovenous malformation treated successfully by embolisation 1
More informationEndovascular Treatment of Cerebral Arteriovenous Malformations. Bs. Nguyễn Ngọc Pi Doanh- Bs Đặng Ngọc Dũng Khoa Ngoại Thần Kinh
Endovascular Treatment of Cerebral Arteriovenous Malformations Bs. Nguyễn Ngọc Pi Doanh- Bs Đặng Ngọc Dũng Khoa Ngoại Thần Kinh Stroke Vascular Malformations of the Brain Epidemiology: - Incidence: 0.1%,
More informationSelected radiosurgery cases from the Rotating Gamma Institute Debrecen, Hungary
Selected radiosurgery cases from the Rotating Gamma Institute Debrecen, Hungary László Bognár M.D., Ph.D., József G. Dobai M.D., Gábor Csiky and Imre Fedorcsák M.D., Ph.D. Department of Neurosurgery, Medical
More informationNeurosurgery Review. Mudit Sharma, MD May 16 th, 2008
Neurosurgery Review Mudit Sharma, MD May 16 th, 2008 Dr. Mudit Sharma, Neurosurgeon Manassas, Fredericksburg, Virginia http://www.virginiaspinespecialists.com Phone: 1-855-SPINE FIX (774-6334) Fundamentals
More informationFRACTIONATED STEREOTACTIC RADIOTHERAPY FOR ACOUSTIC NEUROMAS
PII S0360-3016(02)02763-3 Int. J. Radiation Oncology Biol. Phys., Vol. 54, No. 2, pp. 500 504, 2002 Copyright 2002 Elsevier Science Inc. Printed in the USA. All rights reserved 0360-3016/02/$ see front
More informationFactors Predictive of Obliteration After Arteriovenous Malformation Radiosurgery
ORIGINAL ARTICLE Factors Predictive of Obliteration After Arteriovenous Malformation Radiosurgery C. Herbert, V. Moiseenko, M. McKenzie, G. Redekop, F. Hsu, E. Gete, B. Gill, R. Lee, K. Luchka, A. Lee,
More informationExtracranial doses in stereotactic and conventional radiotherapy for pituitary adenomas
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, VOLUME 7, NUMBER 2, SPRING 2006 Extracranial doses in stereotactic and conventional radiotherapy for pituitary adenomas Thomas Samuel Ram, a Paul B. Ravindran,
More informationLung cancer is the most common malignancy in the. Gamma Knife radiosurgery for the management of cerebral metastases from non small cell lung cancer
clinical article J Neurosurg 122:766 772, 2015 Gamma Knife radiosurgery for the management of cerebral metastases from non small cell lung cancer Greg Bowden, MD, MSc, 1,3,5 Hideyuki Kano, MD, PhD, 1,3
More information7 TI - Radiosurgery of angiographically occult vascular malformations. AU - Kida Y, et al.
1 TI - Cerebral arteriovenous malformation in pregnancy: presentation and neurologic, obstetric, and ethical significance. AU - Finnerty JJ, et al. SO - Am J Obstet Gynecol. 1999 Aug;181(2):296-303. Review.
More informationThe treatment of brain arteriovenous malformations. Neurologic Complications of Arteriovenous Malformation Embolization Using Liquid Embolic Agents
ORIGINAL RESEARCH M.V. Jayaraman M.L. Marcellus S. Hamilton H.M. Do D. Campbell S.D. Chang G.K. Steinberg M.P. Marks Neurologic Complications of Arteriovenous Malformation Embolization Using Liquid Embolic
More informationParaganglioma of the Skull Base. Ross Zeitlin, MD Medical College of Wisconsin Milwaukee, WI
Paraganglioma of the Skull Base Ross Zeitlin, MD Medical College of Wisconsin Milwaukee, WI Case Presentation 63-year-old female presents with right-sided progressive conductive hearing loss for several
More informationThe management of large (> 10 cm3) arteriovenous
Neurosurg Focus 37 (3):E18, 2014 AANS, 2014 Volume-staged versus dose-staged radiosurgery outcomes for large intracranial arteriovenous malformations Shayan Moosa, B.A., 1 Ching-Jen Chen, M.D., 1 Dale
More information